September 18, 2026
Anthropic brings AI into experimental biology: company opens a bio lab in the San Francisco area
On September 18, 2026, Anthropic opened a lab for physical biological experiments in the San Francisco Bay Area. The company links the work to treating rare diseases, but a spokesperson clarified that the lab is not specifically intended for drug development.
Anthropic has taken its biology work beyond computer-based evaluations by adding physical experiments. Claude is expected to operate robotic setups with limited human involvement, though Anthropic considers human oversight necessary.
The company plans preclinical research in areas that the traditional pharmaceutical industry considers financially unattractive. Anthropic is not conducting clinical trials yet, so the project remains at the lab stage.
The project remains at the preclinical research stage for now: Anthropic is not conducting clinical trials.
Source
